Montag & Caldwell’s CR Bard Inc. BCR Stock Holding History

Montag & Caldwell’s Portfolio BCR Stock Details BCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,501	Closed	-$870K	–	93
2017 Q1	$870K	Buy	+3,501	New	+$844K	0.02%	53

Other funds holding BCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACPU

Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Montag & Caldwell's BCR Position: Q2 2017 in Review

Montag & Caldwell sold out of CR Bard Inc. (BCR) in Q2 2017, closing a stake of 3,501 shares — an estimated $870K sold.

Montag & Caldwell first reported a position in BCR in Q1 2017 and held it in 1 quarter. The position peaked at $870K in Q1 2017. 675 funds tracked by Wall St. Rank hold BCR as of Q2 2017.

Montag & Caldwell reported no remaining CR Bard Inc. position as of Q2 2017 after selling out during the quarter.
Montag & Caldwell sold 3,501 CR Bard Inc. shares in Q2 2017, an estimated $870K.
Montag & Caldwell first reported a position in CR Bard Inc. in Q1 2017 and held it in 1 quarter.
Montag & Caldwell's CR Bard Inc. position peaked at $870K in Q1 2017.
675 funds tracked by Wall St. Rank held CR Bard Inc. as of Q2 2017.

Based on Montag & Caldwell's 13F filing for Q2 2017, filed 2 Aug 2017.